Crossmark

(−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells

Published Online: 2019-10-14

Published Print: 2019-12

Authors

Wang, Jing https://orcid.org/0000-0001-6143-5858
Sun, Peiyuan

Wang, Qi

Zhang, Pan

Wang, Yuna

Zi, Chengting

Wang, Xuanjun

Sheng, Jun
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (21602196)

College of Engineering, University of Canterbury (2017HA015)

College of Engineering, University of Canterbury (2015HB037)

Yunnan Agricultural University Natural Science Foundation for Young Scientists (2015ZR08)
License Information

Text and Data Mining valid from 2019-10-14

Version of Record valid from 2019-10-14
More Information

Article History

Received: 5 July 2019

Accepted: 27 September 2019

First Online: 14 October 2019

Ethics approval and consent to participate

: Experimental research on nude mice comply with Yunnan Agricultural University guidelines. The animal experiment has been approved by ethics committee.

: This is not applicable for this study.

: The authors declare that they have no competing interests.

Document is current